Press Releases
Vicero Appoints Dr. Han Myint as Chief Medical Officer
September 9, 2025 Global oncology leader brings decades of experience advancing breakthrough therapies to help guide Vicero’s VVH VINCOBODY pipeline [...]
Vicero Welcomes Renowned Cancer Immunotherapy Experts to its Scientific Advisory Board
March 24, 2025 Dr. Sumit Subudhi and Dr. Antoni Ribas bring world-class expertise in immuno-oncology to help guide development of [...]
Vicero’s Novel Cancer Immunotherapy Demonstrates Dual-Target Precision with Improved Safety Profile
February 24, 2025 Late-breaker poster presentation at the inaugural AACR IO underscores potential of VCR-036, a novel PD-1/CTLA-4 VHH antibody [...]
